Ovation Science Secures Listing for DermSafe on Amazon.ca to Increase Direct to Canadian Consumer Purchases

Ovation Science (CSE OVAT)
Published on: October 28, 2020

Pharmaceutical-Grade Hand Sanitizer Available for Sale Across Canada

Vancouver, BC – October 28th , 2020 (CSE: OVAT) – Ovation Science Inc. (“Ovation” or the “Company”) is pleased to announce that its DermSafe® Hand Sanitizer Lotion is listed on Amazon.ca. The product listing offered on Amazon.ca and can be purchased by both regular and prime members.

To purchase DermSafe: Just search for “DermSafe” in Amazon.ca’s search engine or click on amazon.ca/shops/dermsafe.

“We are excited that we have increased the availability of DermSafe to consumers in Canada through Amazon.ca, Canada’s largest online channel. We have heard great feedback already from people that use DermSafe regularly and how protected they feel when they have it on. Now with the distribution by Amazon there will be greater access for Canadians as well as quicker delivery times, especially for an important product like DermSafe that will help people fight the battle against this pandemic,” said Mr. Terry Howlett, President of Ovation. “Amazon also provides consumers with the ability to receive free shipping if they are Prime members; a substantial advantage when purchasing DermSafe.” He added, “We have launched the personal use on Amazon.ca, a 59ml sized bottle as well as have offered a discount with the purchase of three bottles. We also continue to sell DermSafe through our Canadian distributors. Along with the 59ml bottle, they offer a commercial use 236ml bottle with a precise pump for dispensing that “dime-size” amount of DermSafe lotion which is all you need.”

In conjunction with the launch on Amazon.ca, Ovation has updated its DermSafe.com website. This website provides further information about DermSafe as well as the ability to purchase the product through Amazon. For bulk / commercial sales of DermSafe please contact one of our Canadian distributors or email us directly at [email protected]

According to Statista.com in late 2019, e-commerce retail trade sales amounted to almost 1.85 billion Canadian dollars, with approximately 28.1 million Canadians having made purchases online. Furthermore, according to a Statistics Canada report (“Retail e-commerce and COVID-19: How online shopping opened doors while many were closing”, July 2020), from February to May 2020, retail e-commerce sales nearly doubled (+99.3%). A JP Morgan report (“E-commerce Payments Trends: Canada”) reports that Amazon is Canada’s most popular website and 21% of Canada’s online shoppers hold an Amazon Prime account.

DermSafe is listed by Health Canada under its approved products “Disinfectants and hand sanitizers accepted under COVID-19 interim measure” and has two Drug Identification Numbers (DIN) for personal use and personal commercial use. DermSafe is a pharmaceutical-grade hand sanitizer lotion made without alcohol and backed by science. Unlike alcohol hand sanitizers, DermSafe does not dry out your hands and it offers the persistent protection of chlorhexidine gluconate; an ingredient used worldwide as a pre-surgical soap due to its proven abilities to kill germs. DermSafe is also powered by Invisicare®, a proprietary polymer delivery system that enhances how products stay on the skin and how it delivers drugs to the skin. Statements have not been evaluated by Health Canada. These products are not intended to diagnose, treat, cure, or prevent any disease.

For information about DermSafe and to order visitdermsafe.com

For information about Ovation Science products visitovationscience.com/products/.

Statements have not been evaluated by Health Canada. These products are not intended to diagnose, treat, cure, or prevent any disease.

Ovation Science Inc.

Ovation Science Inc. is a research and development company that develops topical and transdermal consumer products including DermSafe, all made with patented Invisicare® skin delivery technology. The technology enhances the delivery of ingredients to and through the skin and is protected by patents in eleven countries. With over twenty years of topical and transdermal drug delivery experience in the pharmaceutical market, Ovation’s management and science team have created a unique pipeline of over twenty-five patent-protected medical / wellness topical and transdermal products along with a line of anti-aging / beauty formulas. Ovation earns revenues from licensing and development fees, royalties, the sale of Invisicare to its licensees and now revenue from its own product sales. Ovation has offices in Vancouver, BC Canada and Las Vegas, Nevada, USA. Ovation trades on the CSE under the symbol OVAT. Visit our website ovationscience.com.

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. In particular there is no assurance of sales on Amazon or through distributors. There are no guarantees of future performance. Ovation Science Inc. cautions that all forward looking statements are inherently uncertain and that actual results may be affected by a number of material factors, many of which are beyond Ovation Science Inc.’s control. Accordingly, readers should not place undue reliance on the forward-looking information. Ovation disclaims any obligation to revise or update any such forward-looking information to reflect future results, events or circumstances, except as required by law.

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

CONTACT:

FOR INVESTOR RELATIONS:

Sebastian Kunyz:

[email protected]

Phone: 604-684-6730 or Toll Free at 866-684-6730

FOR BUSINESS DEVELOPMENT & CORPORATE INQUIRIES:

Doreen McMorran:

[email protected]

Phone:  604.283.0903 ext. 4

Cannabis Healthcare Life Science